An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancer
Title:
An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancer
Author:
Montazeri, K. Dranitsaris, G. Thomas, JD. Curran, C. Preston, MA. Steele, GS. Kilbridge, KL. Mantia, C. Ravi, P. McGregor, BA. Mossanen, M. Sonpavde, G.